Developer docs
API playgroundTry for free, no card

Search company profiles

Intan Technologies

Full company profile

uuid000io7m

Namestring
Intan Technologies
Websiteurl
intantech.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Intan Technologies is a privately held, Los Angeles-based company founded in 2010 with a 1-10 employee footprint that develops high-density electromyography (HD-EMG) interfaces and spatial-based machine learning algorithms for controlling upper-limb prosthetic devices. The company's stated problem is translating laboratory HD-EMG prosthetic control prototypes into clinically viable commercial solutions with fully integrated hardware and software, targeting the medical-device/prosthetics vertical and aiming to reduce the approximately 44% prosthesis abandonment rate through improved control interfaces.

The firm's proprietary HD-EMG Interface Technology is positioned on accuracy and precision in recording muscle signals, paired with spatial-based ML control algorithms to interpret intent from dense electrode arrays. Publicly available commercial evidence is limited: the company website (intantech.com) displays only a loading/verification page, no products, pricing, distribution channels, marketing channels, customer logos, funding rounds, partnerships, management roster, or regulatory milestones are disclosed in the source material.

The business model is not publicly described. Revenue mechanics, pricing models, OEM relationships, and contract structures are all unspecified, and the company has no disclosed investors or subsidiaries. Given the single-vertical focus on prosthetic control interfaces, the company appears positioned as a niche technology/component provider to medical-device OEMs or clinical research programs, but the absence of disclosed commercial traction makes any revenue characterization speculative.

Short descriptiontext

Intan Technologies is a Los Angeles-based company founded in 2010 that builds high-density electromyography (HD-EMG) interfaces and spatial-based machine learning algorithms for upper-limb prosthetic control, targeting the medical-device/prosthetics vertical to reduce prosthesis abandonment rates.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
bioelectronic microchips, electrophysiology interfaces, HD-EMG sensors, prosthetic control systems, neural signal acquisition
Industry2 codes
PRIMARYHLAHAEAH
Limb Prosthetics (Upper/Lower Extremity Prosthetic Systems)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHDAHAIAJ
Analog Front-End (AFE) ICs (Sensor/Medical/Industrial AFE)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Instrument Manufacturing for Measuring and Testing Electricity and Electrical Signals334515
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Instruments For Meas & Testing Of Electricity & Elec Signals3825
Product category
Bioelectronic Microchips
Social media profiles1 record
Cost components5 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Intan Technologies designs and manufactures specialized microchips and electrophysiology interfaces for sensing weak electrical signals from biological systems. The company's primary commercial focus is on high-density electromyography (HD-EMG) recording interfaces coupled with spatial-based machine learning algorithms for controlling upper-limb prosthetic devices. Its work centers on translating laboratory HD-EMG prototypes into clinically viable, fully integrated hardware-and-software prosthetic control solutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Targeting reduction of approximately 44% prosthesis abandonment rates
Product overview1 text field

No product information available in the provided source data. The available sources consist of a scientific article about HD-EMG (high-density electromyography) technology for prosthetic control and a placeholder webpage from intantech.com that did not load content.

Product and service1 record
1HD-EMG Interface Technology
Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Manufactures high-channel-count neural recording systems using proprietary low-noise amplifiers — closely comparable bio-signal acquisition chip capability.

TypeEmerging player
Description

Open-source bio-signal acquisition hardware (EEG/EMG/ECG); serves the same research-oriented bio-signal recording market with lower-cost, lower-channel-count systems.

TypeBroad incumbent
Description

Major prosthetics manufacturer with growing bionic upper-limb portfolio; comparable end-market dynamics and potential OEM customer for Intan's interface modules.

TypeBroad incumbent
Description

Global leader in upper-limb prosthetics; could be both a customer channel and a competitive threat for Intan's prosthetic-control technology.

TypeDirect peer
Description

Coapt develops pattern-recognition myoelectric control systems for upper-limb prosthetics using EMG signals — directly comparable to Intan's HD-EMG + ML prosthetic-control focus.

TypeDirect peer
Description

Designs low-noise neural and bio-signal acquisition chips and systems for research and clinical use — directly comparable analog-front-end bio-signal chip design capability.

TypeEmerging player
Description

Develops EMG-based prosthetic hand control and brain-interface wearables; intersects Intan's prosthetics application with consumer-grade scale ambitions.

TypeBroad incumbent
Description

Develops high-channel-count implantable brain-computer interfaces with proprietary low-noise ASICs — comparable bio-signal chip ambition, though at far larger scale and capital intensity.

TypeEmerging player
Description

Designs high-density neural probes and recording systems for neuroscience; overlaps with Intan on the bio-signal acquisition stack for research applications.

TypeDirect peer
Description

IBT builds EMG-based control systems and sensors for prosthetic limbs; one of the closest US competitors addressing the same HD-EMG-to-prosthetic workflow Intan targets.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Intan Technologies

Bioelectronic Microchipsintantech.com

Intan Technologies is a Los Angeles-based company founded in 2010 that builds high-density electromyography (HD-EMG) interfaces and spatial-based machine learning algorithms for upper-limb prosthetic control, targeting the medical-device/prosthetics vertical to reduce prosthesis abandonment rates.

What Intan Technologies does

Intan Technologies is a privately held, Los Angeles-based company founded in 2010 with a 1-10 employee footprint that develops high-density electromyography (HD-EMG) interfaces and spatial-based machine learning algorithms for controlling upper-limb prosthetic devices. The company's stated problem is translating laboratory HD-EMG prosthetic control prototypes into clinically viable commercial solutions with fully integrated hardware and software, targeting the medical-device/prosthetics vertical and aiming to reduce the approximately 44% prosthesis abandonment rate through improved control interfaces.

The firm's proprietary HD-EMG Interface Technology is positioned on accuracy and precision in recording muscle signals, paired with spatial-based ML control algorithms to interpret intent from dense electrode arrays. Publicly available commercial evidence is limited: the company website (intantech.com) displays only a loading/verification page, no products, pricing, distribution channels, marketing channels, customer logos, funding rounds, partnerships, management roster, or regulatory milestones are disclosed in the source material.

The business model is not publicly described. Revenue mechanics, pricing models, OEM relationships, and contract structures are all unspecified, and the company has no disclosed investors or subsidiaries. Given the single-vertical focus on prosthetic control interfaces, the company appears positioned as a niche technology/component provider to medical-device OEMs or clinical research programs, but the absence of disclosed commercial traction makes any revenue characterization speculative.

Intan Technologies firmographics

Firmographics
Name
Intan Technologies
Website
https://intantech.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
1–10 employees
Short description
Intan Technologies is a Los Angeles-based company founded in 2010 that builds high-density electromyography (HD-EMG) interfaces and spatial-based machine learning algorithms for upper-limb prosthetic control, targeting the medical-device/prosthetics vertical to reduce prosthesis abandonment rates.
Ownership category
akta.pro rank

Intan Technologies industry classification

Industry
Product category
Bioelectronic Microchips
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Instrument Manufacturing for Measuring and Testing Electricity and Electrical Signals (334515)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Instruments For Meas & Testing Of Electricity & Elec Signals (3825)
akta.pro industry
PRIMARYHLAHAEAH
Limb Prosthetics (Upper/Lower Extremity Prosthetic Systems)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHDAHAIAJ
Analog Front-End (AFE) ICs (Sensor/Medical/Industrial AFE)

Keywords

  • Bioelectronic microchips
  • Electrophysiology interfaces
  • HD-EMG sensors
  • Prosthetic control systems
  • Neural signal acquisition

Where Intan Technologies is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Markets served

Intan Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Intan Technologies product offering

Product offering

Core offering

Intan Technologies designs and manufactures specialized microchips and electrophysiology interfaces for sensing weak electrical signals from biological systems. The company's primary commercial focus is on high-density electromyography (HD-EMG) recording interfaces coupled with spatial-based machine learning algorithms for controlling upper-limb prosthetic devices. Its work centers on translating laboratory HD-EMG prototypes into clinically viable, fully integrated hardware-and-software prosthetic control solutions.

Product overview

No product information available in the provided source data. The available sources consist of a scientific article about HD-EMG (high-density electromyography) technology for prosthetic control and a placeholder webpage from intantech.com that did not load content.

Differentiator

Problem solved

Functional benefit

Products and services

  • HD-EMG Interface Technology

Quantifiable outcome

  • Targeting reduction of approximately 44% prosthesis abandonment rates

Companies that use Intan Technologies

Customer profile

Segments1 record

Ideal customer profiles1 record

Intan Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Intan Technologies partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights2 records

Intan Technologies competitors and assessment

Company assessment

Direct peers

  • Ripple Neuro: Manufactures high-channel-count neural recording systems using proprietary low-noise amplifiers — closely comparable bio-signal acquisition chip capability.
  • Coapt: Coapt develops pattern-recognition myoelectric control systems for upper-limb prosthetics using EMG signals — directly comparable to Intan's HD-EMG + ML prosthetic-control focus.
  • Blackrock Microsystems: Designs low-noise neural and bio-signal acquisition chips and systems for research and clinical use — directly comparable analog-front-end bio-signal chip design capability.
  • Infinite Biomedical Technologies: IBT builds EMG-based control systems and sensors for prosthetic limbs; one of the closest US competitors addressing the same HD-EMG-to-prosthetic workflow Intan targets.

Emerging players

  • OpenBCI: Open-source bio-signal acquisition hardware (EEG/EMG/ECG); serves the same research-oriented bio-signal recording market with lower-cost, lower-channel-count systems.
  • BrainCo: Develops EMG-based prosthetic hand control and brain-interface wearables; intersects Intan's prosthetics application with consumer-grade scale ambitions.
  • Cambridge NeuroTech: Designs high-density neural probes and recording systems for neuroscience; overlaps with Intan on the bio-signal acquisition stack for research applications.

Broad incumbents

  • Össur: Major prosthetics manufacturer with growing bionic upper-limb portfolio; comparable end-market dynamics and potential OEM customer for Intan's interface modules.
  • Ottobock: Global leader in upper-limb prosthetics; could be both a customer channel and a competitive threat for Intan's prosthetic-control technology.
  • Neuralink: Develops high-channel-count implantable brain-computer interfaces with proprietary low-noise ASICs — comparable bio-signal chip ambition, though at far larger scale and capital intensity.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

Intan Technologies social profiles

Digital presence

Intan Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Intan Technologies leadership team

Management profile

Number of profiles

Intan Technologies funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Intan Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intan Technologies

What does Intan Technologies do?

Intan Technologies designs and manufactures specialized microchips and electrophysiology interfaces for sensing weak electrical signals from biological systems. The company's primary commercial focus is on high-density electromyography (HD-EMG) recording interfaces coupled with spatial-based machine learning algorithms for controlling upper-limb prosthetic devices. Its work centers on translating laboratory HD-EMG prototypes into clinically viable, fully integrated hardware-and-software prosthetic control solutions.

When was Intan Technologies founded?

Intan Technologies was founded in 2010. It employs 1 to 10 people.

Where is Intan Technologies based?

Intan Technologies is headquartered in Los Angeles, United States, in the North America region.

Who are Intan Technologies's main competitors?

Direct peers on record are Ripple Neuro, Coapt, Blackrock Microsystems and Infinite Biomedical Technologies. Emerging players are OpenBCI, BrainCo and Cambridge NeuroTech. Broad incumbents are Össur, Ottobock and Neuralink.

Does Intan Technologies have an API?

No public API is recorded for Intan Technologies.

What industry is Intan Technologies in?

Intan Technologies's product category is Bioelectronic Microchips. Its primary akta.pro industry code is HLAHAEAH, Limb Prosthetics (Upper/Lower Extremity Prosthetic Systems), with a secondary code of HDAHAIAJ, Analog Front-End (AFE) ICs (Sensor/Medical/Industrial AFE). Its NAICS code is 334510 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals